John Depaula, MD
Infectious Disease · Metairie, LANPI 1356447635
Payments from drug & device makers
Across 930 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$4K
- Gilead$2K
- Paratek Pharmaceuticals, Inc.$2K
- AbbVie$1K
- Merck$1K
- Insmed, Inc.$1K
- plus $5K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 214 | $4,095 |
| Gilead | 110 | $2,102 |
| Paratek Pharmaceuticals, Inc. | 110 | $1,833 |
| AbbVie(2 entities) | 80 | $1,265 |
| Merck | 74 | $1,236 |
| Insmed, Inc. | 61 | $1,101 |
| Johnson & Johnson(2 entities) | 69 | $1,013 |
| Theratechnologies Inc. | 32 | $752 |
| Melinta Therapeutics, LLC | 36 | $633 |
| Astellas Pharma US Inc | 26 | $605 |
| EMD Serono, Inc. | 22 | $474 |
| Shionogi Inc | 16 | $283 |
| Napo Pharmaceuticals Inc | 15 | $276 |
| Pfizer | 12 | $211 |
| Amarin Pharma, Inc. | 10 | $200 |
| Ferring Pharmaceuticals Inc. | 7 | $113 |
| Accelerate Diagnostics Inc. | 2 | $87 |
| La Jolla Pharmaceutical Company | 5 | $79 |
| Qiagen, LLC | 1 | $75 |
| Smith+Nephew | 3 | $74 |
| Mayne Pharma Commercial LLC | 3 | $67 |
| Invivyd Inc | 3 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $50 |
| Organogenesis Inc. | 1 | $48 |
| Tetraphase Pharmaceuticals, Inc. | 3 | $46 |
| Cumberland Pharmaceuticals, Inc. | 3 | $42 |
| Tactile Systems Technology Inc | 2 | $35 |
| Janssen Products, LP | 1 | $30 |
| Vyera Pharmaceuticals, LLC | 1 | $25 |
| Nabriva Therapeutics, PLC | 2 | $23 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $15 |
How this compares
$16,982 in reported general payments places this provider in the 75th percentile of 105 infectious disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Metairie
- Frank RabitoMetairie$13K
- Anish ShahMetairie$4K
- Diane FaillaMetairie$2K
- Julia Garcia-DiazNew Orleans$9.9M
- Rebecca LillisNew Orleans$2.7M
- Jonathan HandNew Orleans$1.7M
- Stephanie TaylorNew Orleans$1.6M
- George PankeyNew Orleans$851K
- Meredith ClementNew Orleans$829K
- Joseph DalovisioNew Orleans$634K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.